Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

61.60 +1.54 (+2.56%)
Official Closing Price Updated: 4:10 PM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,380,798
Open 59.87
Bid (Size) 61.62 (4)
Ask (Size) 61.80 (10)
Prev. Close 60.06
Today's Range 59.76 - 62.01
52wk Range 52.77 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 3.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of CVS Health Corporation (CVS) Investors
From Law Offices of Howard G. Smith
Via Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire

Performance

YTD
-23.81%
-23.81%
1 Month
+0.83%
+0.83%
3 Month
-10.76%
-10.76%
6 Month
-20.43%
-20.43%
1 Year
-13.45%
-13.45%

More News

Read More
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Market Whales and Their Recent Bets on CVS Options
Via Benzinga
CVS Health's Options Frenzy: What You Need to Know
Via Benzinga
Behind the Scenes of CVS Health's Latest Options Trends
Via Benzinga
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against CVS Health Corporation (CVS)
From Robbins LLP
Via GlobeNewswire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
CVS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces That CVS Health Corporation Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Check Out What Whales Are Doing With CVS
Via Benzinga
CVS HEALTH CORPORATION (NYSE: CVS) INVESTOR ALERT: Investors With Large Losses in CVS Health Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
CVS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that CVS Health Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Rosen Law Firm Urges CVS Health Corporation (NYSE: CVS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
3 Spinoff Stocks You Should Buy Now: July 2024
Via InvestorPlace
3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends
Via InvestorPlace
Topics Retirement
Exposures Pension
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Via Benzinga
Topics Cannabis
Exposures Cannabis
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
Via MarketBeat
7 High-Yield Dividend Stocks to Buy and Hold Forever: July Edition
Via InvestorPlace
3 Underdog Stocks Set to Skyrocket This Year
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth
Via Benzinga
3 Bargain Stocks With the Potential for Mind-Boggling Returns
Via InvestorPlace
The Next Blockbuster?
Via Talk Markets
Bitcoin Dip Not Over Yet Or The Shorts Are About To Get 'Obliterated,' Says Ali Martinez
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.